Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons
About Us
SnackSafely.com Media Kit
SnackSafely.com Advertising Guide
Subscribe to our newsletter
Contact Us
Resources
FAQ
Partner Manufacturers
Tools for Schools
Coupons
Inspiring Food Allergy Bloggers and Authors
Search
Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons
About Us
SnackSafely.com Media Kit
SnackSafely.com Advertising Guide
Subscribe to our newsletter
Contact Us
Resources
FAQ
Partner Manufacturers
Tools for Schools
Coupons
Inspiring Food Allergy Bloggers and Authors
Search
Tag: European Academy of Allergy Asthma and Immunology (EAACI)
Breast Milk from Mennonite Moms on Farms May Better Protect Babies...
News Wire ~ 3rd Party Press Release
-
2021/11/23
Women from traditional farming communities may pass protection against atopic diseases through their milk.
Anaphylaxis Management: EAACI Updates Guidelines Raising Epinephrine to First-Line Treatment
Dave Bloom
-
2021/08/30
There's just no doubt: epinephrine is the first-line treatment for anaphylaxis.
Study: More Than 80% of Patients Could Tolerate 2000mg of Peanuts...
News Wire ~ 3rd Party Press Release
-
2021/08/05
Safety and efficacy increased over time with treatment.
AllerGenis Lauds Study Results of New, More Accurate Blood Test for...
News Wire ~ 3rd Party Press Release
-
2021/06/15
"Test brings us one step closer to eliminating the need to subject patients to an oral food challenge."
Learn the Biology of Food Allergy in 7 Minutes With These...
Dave Bloom
-
2021/05/12
These videos will give you a solid understanding of how one develops food allergies and what happens in the body during a reaction.
Wrongly Labeled: Challenges and Ways Forward in Food Allergen Labeling
News Wire ~ 3rd Party Press Release
-
2020/10/27
What must be done to improve allergen labeling.
Aravax Presents Additional Positive Phase I Trial Results for PVX108, a...
News Wire ~ 3rd Party Press Release
-
2019/06/05
Trial results demonstrate excellent PVX108 safety profile in patients with prior anaphylaxis and current asthma.
Phase 3 Trial Data Demonstrates Consistent Safety and Efficacy of AR101...
Dave Bloom
-
2019/06/03
“Results of the European ARTEMIS trial provide further clinical validation of the safety and efficacy of AR101 for children and adolescents with peanut allergy.”
European Phase 3 Trial of AR101 Peanut OIT Candidate Meets Primary...
News Wire ~ 3rd Party Press Release
-
2019/03/25
Company Intends to Submit European MAA in Mid-2019.
Peanut OIT Phase 3 Trial Results Show Therapy Effective for Ages...
Dave Bloom
-
2018/05/29
Aimmune plans to submit a Biologics License Application for AR101 to the FDA by the end of 2018.